ArticleProceedings (Baylor University. Medical Center)2026
Atypical immune dysfunction in G6PD deficiency: a case of mosaic neutrophil oxidative burst.
Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked disorder typically causing hemolysis from oxidative damage, but severe variants can impair phagocyte function. While low levels of neutrophil activity are usually sufficient, the interplay of cis-acting regulatory elements and variable X-inactivation can lead to atypical clinical presentations. We present the case of a 50-year-old woman with recurrent infections including multiple pneumonias, a pertinent history that includes splenectomy, and genetic tests revealing c.202G > A and c.376A > G variants consistent with G6PD deficiency. G6PD activity in red blood cells was at 2.6 U/g Hb, corresponding to an enzyme activity level of 30% or less, previously classified as class III by the World Health Organization. Neutrophil oxidative burst assay showed a mosaic pattern, indicating both normal and abnormal granulocyte fluorescence. This case highlights that a dihydrorhodamine reduction in G6PD-mutated cells can be mosaic and can mimic X-linked chronic granulomatous disease patterns and that lyonization ratios can vary between hematopoietic lineages, with a potential for clinically relevant neutrophil dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.